Neuroendocrine tumors in the stomach: An epidemiological analysis of Belgian Cancer Registry data 2010–2019
Journal of Neuroendocrinology · 2025
DOI: 10.1111/jne.13473 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuroendocrinology, 2025. Verfasst von Marlies Maly und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium. Hauptthemen laut MEDLINE: Stomach Neoplasms, Neuroendocrine Tumors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
The prevalence of gastric NEN is estimated worldwide at 8.9% of all gastroenteropancreatic neuroendocrine neoplasm (GEP‐NEN) and only 0.3%–1% of all gastric neoplasms, but is rising in the last decades. The aim of this project was to map the epidemiology of gastric neuroendocrine neoplasm (gNEN) in Belgium. This is a population‐wide retrospective cohort study over 10 years (2010–2019), based on data from the Belgian Cancer Registry. A total of 641 patients were included; 605 patients with gNEN and 36 with MiNEN. The AAIR of gNEN was 0.67 per 100,000 person‐years, increasing over the years and with a slight female predominance (55.4%). Neuroendocrine carcinoma (NEC) accounted for 15.7% ( N = 95), with an AAIR of 0.11 per 100,000 person‐years. The other 510 patients were diagnosed with gNET: G1 NET was most prevalent (54.3%) followed by G2 (32.5%) and G3 NET (3.5%). Concerning the clinical classification (type) of gNET, a diagnosis of type 1 tumors was presumed in 67.6%, type 3 tumors in 17.1% and type 2 tumors in 0.6% of patients. In only 3.8% of patients, the clinical classification was explicitly stated in the pathology report. Stage IV tumors were diagnosed in 13.4% ( N = 81). A favorable evolution in pathology reporting is seen. Some variables—for example, clinical classification of gNET—were heavily underreported, stressing the importance of registries integrating clinical and pathological information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium.
- Department of Pathology, Ghent University Hospital, Ghent, Belgium.
- Department of Gastroenterology and Digestive Oncology, Imelda General Hospital, Bonheiden, Belgium.
- NETwerk and Department of Oncology, Antwerp University Hospital and University of Antwerp, Antwerp, Belgium.
- Gastroenterology Department, UCLouvain, Louvain, Belgium.
- Department of Pathology, Institut Jules Bordet, ULB, Brussels, Belgium.
ORCID-Profile: Marlies Maly, Eduard Callebout
Zitieren
APA
Maly, M., Callebout, E., Ribeiro, S., Hoorens, A., Carton, S., Cuyle, P. J., Vandamme, T., Borbath, I., Demetter, P., Van Damme, N., Van Eycken, L., Verslype, C., & Geboes, K. (2025). Neuroendocrine tumors in the stomach: An epidemiological analysis of Belgian Cancer Registry data 2010–2019. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.13473
Vancouver
Maly M, Callebout E, Ribeiro S, Hoorens A, Carton S, Cuyle PJ, et al. Neuroendocrine tumors in the stomach: An epidemiological analysis of Belgian Cancer Registry data 2010–2019. Journal of Neuroendocrinology. 2025. doi:10.1111/jne.13473
BibTeX
@article{Maly2025,
author = {Maly, Marlies and Callebout, Eduard and Ribeiro, Suzane and Hoorens, Anne and Carton, Saskia and Cuyle, Pieter-Jan and Vandamme, Timon and Borbath, Ivan and Demetter, Pieter and Van Damme, Nancy and Van Eycken, Liesbet and Verslype, Chris and Geboes, Karen},
title = {Neuroendocrine tumors in the stomach: An epidemiological analysis of Belgian Cancer Registry data 2010–2019},
journal = {Journal of Neuroendocrinology},
year = {2025},
doi = {10.1111/jne.13473}
}
EUVIMED